These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26935290)

  • 1. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro.
    Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
    Int J Oncol; 2016 May; 48(5):1955-64. PubMed ID: 26935290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive effects of exogenous regucalcin on the proliferation of human pancreatic cancer MIA PaCa-2 cells in vitro.
    Yamaguchi M; Murata T
    Int J Mol Med; 2015 Jun; 35(6):1773-8. PubMed ID: 25847529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged survival of patients with colorectal cancer is associated with a higher regucalcin gene expression: Overexpression of regucalcin suppresses the growth of human colorectal carcinoma cells in vitro.
    Yamaguchi M; Osuka S; Murata T
    Int J Oncol; 2018 Sep; 53(3):1313-1322. PubMed ID: 29956741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro.
    Yamaguchi M; Osuka S; Weitzmann MN; Shoji M; Murata T
    Int J Oncol; 2016 Aug; 49(2):812-22. PubMed ID: 27221776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged survival in hepatocarcinoma patients with increased regucalcin gene expression: HepG2 cell proliferation is suppressed by overexpression of regucalcin in vitro.
    Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
    Int J Oncol; 2016 Oct; 49(4):1686-94. PubMed ID: 27633001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged survival of renal cancer patients is concomitant with a higher regucalcin gene expression in tumor tissues: Overexpression of regucalcin suppresses the growth of human renal cell carcinoma cells in vitro.
    Yamaguchi M; Osuka S; Hankinson O; Murata T
    Int J Oncol; 2019 Jan; 54(1):188-198. PubMed ID: 30387835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of lung cancer patients is prolonged with higher regucalcin gene expression: suppressed proliferation of lung adenocarcinoma A549 cells in vitro.
    Yamaguchi M; Osuka S; Shoji M; Weitzmann MN; Murata T
    Mol Cell Biochem; 2017 Jun; 430(1-2):37-46. PubMed ID: 28181135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of regucalcin suppresses cell proliferation in cloned rat hepatoma H4-II-E cells: involvement of intracellular signaling factors and cell cycle-related genes.
    Yamaguchi M; Daimon Y
    J Cell Biochem; 2005 Aug; 95(6):1169-77. PubMed ID: 15962315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatively spliced variants of the regucalcin gene in various human normal and tumor tissues.
    Murata T; Yamaguchi M
    Int J Mol Med; 2014 Oct; 34(4):1141-6. PubMed ID: 25050833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C
    Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells.
    Tanouchi A; Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Kimura M; Watanabe R; Kohsaki T; Shimizu T; Saito M; Hanazaki K; Saibara T
    J Exp Clin Cancer Res; 2016 Dec; 35(1):190. PubMed ID: 27919290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
    Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
    Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
    BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway.
    Liu D; Zhang J; Wu Y; Shi G; Yuan H; Lu Z; Zhu Q; Wu P; Lu C; Guo F; Chen J; Jiang K; Miao Y
    Int J Cancer; 2018 Apr; 142(7):1392-1404. PubMed ID: 29168185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Regucalcin Suppresses the Growth of Human Osteosarcoma Cells
    Yamaguchi M; Murata T
    Cancer Invest; 2020 Jan; 38(1):37-51. PubMed ID: 31868021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The calcium channel agonist Bay K 8644 promotes the growth of human liver cancer HepG2 cells in vitro: suppression with overexpressed regucalcin.
    Yamaguchi M; Murata T; Ramos JW
    Mol Cell Biochem; 2020 Sep; 472(1-2):173-185. PubMed ID: 32591915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
    Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
    Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.